The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    Discussions on raising age for free subway rides gain momentum

  • 3

    Families of Itaewon crowd stampede victims clash with police over installation of memorial altar

  • 5

    US reaffirms nuclear security assurances to South Korea

  • 7

    Families of Itaewon victims on collision course with Seoul City

  • 9

    William Franklin Sands' diplomatic and undiplomatic views of late Joseon

  • 11

    Will KT, POSCO replace CEOs as Shinhan, Woori did?

  • 13

    Korea as sublime, strange, and familiar

  • 15

    TXT, Le Sserafim top Oricon album and singles chart

  • 17

    Chinese spy balloon 'transits' Latin America after first craft flies over US

  • 19

    Blinken scraps rare China trip over alleged spy balloon

  • 2

    INTERVIEWTati Gabrielle, actress of Korean, African-American descent, feels proud of her heritage

  • 4

    2-year work experience prerequisite lifted for foreign shipyard welders

  • 6

    China expresses 'strong dissatisfaction' over US shooting down balloon

  • 8

    Opposition party takes to streets to protest prosecution probes into leader

  • 10

    Korean American Rep. Young Kim named chair of House Indo-Pacific subcommittee

  • 12

    US remains committed to using full range of capabilities to defend S. Korea: Blinken

  • 14

    US shoots down suspected Chinese spy balloon with a single missile

  • 16

    Wang Yi urges US to 'avoid misjudgment' over balloon controversy

  • 18

    President Yoon at odds with politician who helped him win election

  • 20

    Musk didn't defraud investors with 2018 Tesla tweets

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
Business
Bio
  • Tech
  • Bio
  • Companies
Mon, February 6, 2023 | 20:54
SK Biopharm signs deal to commercialize anti-epileptic drug in Latin America
SK Biopharm signs deal to commercialize anti-epileptic drug in Latin America
SK Biopharmaceuticals, a biopharmaceutical affiliate of Korea's SK Group, said Thursday it has signed a deal with Eurofarma Laboratorios SA to develop and commercialize its anti-epileptic drug Cenobamate in 17 Latin American countries.
2022-07-14 14:26
'SK Bioscience's vaccine effective against Omicron variant'
'SK Bioscience's vaccine effective against Omicron variant'
SK Bioscience's SKYCovione coronavirus vaccine was proven to be effective against the Omicron variant. The company said Wednesday that it confirmed the effective immune response when people received a booster shot of the vaccine. SKYCovione, also known as GBP510, is Korea's first COVID-19 vaccine. SK Bioscience obtained approval for the use of the recombinant protein-based va...
Baek Byung-yeul | 2022-07-13 16:05
HanAll Biopharma set to expand presence in Asia with autoimmune treatment
HanAll Biopharma set to expand presence in Asia with autoimmune treatment
Local biotech company HanAll Biopharma is seeking to expand its presence in Asia, as the company is set to begin Phase 3 clinical testing of its autoimmune disease treatment candidate in Japan in the second half of 2022, the company said Monday.
Baek Byung-yeul | 2022-07-11 16:58
SD Biosensor to acquire US diagnostic firm Meridian for $1.53 bil.
SD Biosensor to acquire US diagnostic firm Meridian for $1.53 bil.
SD Biosensor, a local biotech company known for its COVID-19 test kits, said Friday that it agreed to acquire U.S.-based diagnostic company Meridian Bioscience for 2 trillion won ($1.53 billion). This is the largest amount for an M&A deal in the domestic bio industry.
Baek Byung-yeul | 2022-07-08 16:48
Korea's bio industry at turning point after pandemic
Korea's bio industry at turning point after pandemic
SK Bioscience, Samsung Biologics and other Korean biotech companies are soaring to new heights as they succeed in locally developing vaccines, winning orders to manufacture the drugs and developing treatments for COVID-19, according industry officials, Thursday. “It is obvious that the pandemic raised the importance of securing proprietary vaccine development and manufacturin...
Baek Byung-yeul | 2022-07-03 10:25
SK Bioscience gets final approval for Korea's 1st COVID-19 vaccine
SK Bioscience gets final approval for Korea's 1st COVID-19 vaccine
SK Bioscience's SKYCovione, also known as GBP510, was approved for use, Wednesday, becoming Korea's first locally-developed COVID-19 vaccine to get the green light. The Ministry of Food and Drug Safety (MFDS) announced that it authorized the use of the recombinant protein-based vaccine.
Park Jae-hyuk | 2022-06-29 16:44
Korea approves use of 1st local COVID-19 vaccine from SK Bioscience
Korea approves use of 1st local COVID-19 vaccine from SK Bioscience
The government approved the use of SKYCovione, Wednesday, the country's first locally developed COVID-19 vaccine by SK Bioscience, taking a major step toward achieving vaccine sovereignty in the fight against the pandemic.
2022-06-29 15:02
SK Bioscience COVID-19 vaccine closer to final approval
SK Bioscience COVID-19 vaccine closer to final approval
SK Bioscience has moved one step closer toward rolling out Korea's first COVID-19 vaccine, as the government advisory panel of pharmaceutical experts determined that a license for the use of the vaccine can be granted, according to the Ministry of Food and Drug Safety (MFDS), Monday. “The COVID-19 vaccine developed by SK Bioscience is the first COVID-19 vaccine produced in Ko...
Baek Byung-yeul | 2022-06-27 15:32
[INTERVIEW] Embracing routine PCR test is key to preventing next virus: Seegene CEO
INTERVIEWEmbracing routine PCR test is key to preventing next virus: Seegene CEO
It's the middle of June and there is a chance that the country's new COVID-19 cases will surge again because of a rise in Omicron sub-variants currently being detected in the U.S. and Europe. The U.S. recently lifted its mandatory COVID testing for overseas travelers arriving by plane, which means that visitors no longer need to show negative test results or proof of recovery...
Kim Yoo-chul | 2022-06-16 12:34
SK Bioscience to test own COVID vaccine as booster
SK Bioscience to test own COVID vaccine as booster
SK Bioscience is set to conduct Phase 3 clinical trials of its COVID-19 vaccine in overseas countries to check its effectiveness as a booster shot. The biotech company also expects its vaccine could be approved by a health agency here, according to a company official, Monday.
Baek Byung-yeul | 2022-06-06 16:38
123 4 567
Top 10 Stories
12-year work experience prerequisite lifted for foreign shipyard welders 2-year work experience prerequisite lifted for foreign shipyard welders
2Families of Itaewon victims on collision course with Seoul City Families of Itaewon victims on collision course with Seoul City
3President Yoon at odds with politician who helped him win election President Yoon at odds with politician who helped him win election
49 fishermen, including 2 Vietnamese, missing in boat incident 9 fishermen, including 2 Vietnamese, missing in boat incident
5LG publishes Korea's first group-level net zero report LG publishes Korea's first group-level net zero report
6Conflict reignites over relocation of POSCO Holdings to Pohang Conflict reignites over relocation of POSCO Holdings to Pohang
7FSC approves security token transactions in Korea FSC approves security token transactions in Korea
8[VIDEO] Filipina K-pop idol and K-drama actress react to stereotypes about the Philippines VIDEOFilipina K-pop idol and K-drama actress react to stereotypes about the Philippines
9Hyundai Motor's technology helps team become WTCR double champion Hyundai Motor's technology helps team become WTCR double champion
10Tasks lie ahead for Woori's next chairman nominee picked amid controversy Tasks lie ahead for Woori's next chairman nominee picked amid controversy
DARKROOM
  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

  • World Cup 2022 France vs Morocco

    World Cup 2022 France vs Morocco

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group